Urgent.News

What's breaking now, across thousands of outlets.

Business

Assobiotec, a path to 2036 to transform research into industry

Four priorities: training, technological transfer, research and simplification. Minister Urso: the sector is among those that invest the most and generate the most added value in the EU. Greco: "Create the conditions so that ideas can turn into products and innovation"

Translated from Italian Read in Italian

Assobiotec, a path to 2036 to transform research into industry

Assobiotec-Federchimica has outlined its vision for "Orizzonte Biotech 2036", a plan aimed at transforming innovation and research into production. The association celebrated its 40th anniversary at the Ministry of Enterprises and Made in Italy in Rome, where it presented its growth strategy and highlighted the expansion of the Italian biotechnology ecosystem.

According to recent data, the Italian biotechnology system comprises around 6,000 companies, generating €53.4 billion in revenue and employing over 102,000 people, with a 5% growth in revenue and 4% growth in employment compared to the previous year. The sector has shown significant growth in exports, increasing from €8.5 billion in 2021 to €22 billion in 2025.

Assobiotec-Federchimica President Fabrizio Greco emphasized the need for a long-term vision to support innovation and competitiveness in the sector.

Written by urgent.news from Il Sole 24 Ore's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.

Read the original at ilsole24ore.com →

More in Business

More from Tuesday 17 November →